Vimta Labs Stock Screener | Share Price & Fundamental Analysis
VIMTALABS
Healthcare Technology
Share Price NSE
₹469.30
▼
-6.45 (-1.36%)
Share Price BSE
₹470.10
▼
-6.50 (-1.36%)
Track Vimta Labs share price live with TickJournal's free stock screener.
Analyze Vimta Labs share price history trends and compare 52-week high low
levels.
Calculate VIMTALABS stock fair value using fundamental analysis and view live share price charts.
Determine Vimta Labs share intrinsic value and compare it with current VIMTALABS share price.
Record your Vimta Labs trades in TickJournal's free trading journal and track your portfolio performance.
Vimta Labs Market Cap
₹2,176.86 Cr.
Vimta Labs P/B Ratio
6.10
EPS (TTM)
₹18.51
Dividend Yield
0.21%
Debt to Equity
0.06
VIMTALABS 52 Week High
₹876.00
Vimta Labs 52 Week Low
₹407.40
Operating Margin
37.00%
Profit Margin
23.16%
VIMTALABS Revenue (TTM)
₹95.00
EBITDA
₹38.00
Net Income
₹22.00
Total Assets
₹400.00
Total Equity
₹320.00
Vimta Labs Share Price History - Stock Screener Chart
Screen VIMTALABS historical share price movements with interactive charts. Analyze price trends and patterns.
Vimta Labs Company Profile - Fundamental Screener
Screen Vimta Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VIMTALABS shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE579C01029
Vimta Labs Balance Sheet Screener
Screen VIMTALABS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 400 | 362 | 307 | 274 | 246 |
| Current Assets | 158 | 164 | 124 | 111 | 96 |
| Fixed Assets | 171 | 175 | 169 | 135 | 138 |
| Liabilities | |||||
| Total Liabilities | 400 | 362 | 307 | 274 | 246 |
| Current Liabilities | 26 | 23 | 26 | 26 | 15 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 320 | 282 | 234 | 194 | 173 |
| Share Capital | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 315 | 277 | 230 | 190 | 169 |
Vimta Labs Income Statement Screener - Profit & Revenue Analysis
Screen Vimta Labs income statement and profit fundamentals.
Analyze VIMTALABS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vimta Labs share price evaluation.
| Item | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar | 2021-Dec | 2021-Sept | 2021-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 95 | 85 | 76 | 80 | 75 | 68 | 84 | 83 | 79 | 81 | 80 | 75 | 68 | 76 | 62 |
| Expenses | 57 | 57 | 51 | 55 | 53 | 50 | 59 | 58 | 56 | 55 | 55 | 51 | 47 | 57 | 45 |
| EBITDA | 38 | 29 | 25 | 25 | 23 | 18 | 25 | 25 | 23 | 26 | 25 | 24 | 21 | 19 | 17 |
| Operating Profit % | 37.00% | 33.00% | 32.00% | 31.00% | 29.00% | 24.00% | 30.00% | 30.00% | 28.00% | 32.00% | 30.00% | 31.00% | 31.00% | 25.00% | 27.00% |
| Depreciation | 10 | 8 | 8 | 8 | 8 | 9 | 9 | 8 | 8 | 8 | 7 | 7 | 6 | 6 | 6 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Profit Before Tax | 28 | 20 | 17 | 16 | 14 | 8 | 16 | 17 | 14 | 18 | 17 | 16 | 16 | 13 | 11 |
| Tax | 6 | 5 | 4 | 4 | 3 | 2 | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 3 | 3 |
| Net Profit | 22 | 15 | 12 | 12 | 10 | 6 | 12 | 13 | 10 | 13 | 12 | 12 | 12 | 10 | 8 |
| EPS | 9.65 | 6.88 | 5.54 | 5.58 | 3.61 | 2.86 | 5.51 | 5.73 | 4.62 | 5.97 | 5.45 | 5.36 | 5.28 | 4.41 | 3.65 |
Vimta Labs Cash Flow Screener - Liquidity Fundamentals
Screen VIMTALABS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|
| Operating Activities | 61 | 88 | 59 | 37 | 24 |
| Investing Activities | -76 | -57 | -38 | -32 | -21 |
| Financing Activities | -2 | -11 | -17 | -5 | -1 |
| Net Cash Flow | -17 | 20 | 5 | 1 | 3 |
Vimta Labs Shareholding Pattern Screener
See Vimta Labs shareholding pattern with promoter, FII, and DII holdings.
Check Vimta Labs promoter holding and ownership changes for VIMTALABS on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 36.70% | 36.67% | 35.99% | 35.90% | 36.92% | 36.89% | 36.89% | 36.76% |
| FII Holding | 3.66% | 3.49% | 4.33% | 4.59% | 5.13% | 5.16% | 3.31% | 3.81% |
| DII Holding | 1.43% | 1.42% | 0.87% | 0.11% | 1.50% | 1.49% | 0.00% | 1.16% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 25.17% | 24.02% | 24.62% | 25.12% | 23.08% | 23.13% | 26.53% | 25.09% |
| Other Holding | 33.03% | 34.40% | 34.18% | 34.29% | 33.37% | 33.33% | 33.27% | 33.18% |
| Shareholder Count | 26,183 | 29,867 | 55,933 | 54,467 | 18,550 | 19,054 | 20,114 | 21,156 |
Vimta Labs Share Dividend Screener - Share Yield Analysis
Check Vimta Labs dividend history with payout and yield data.
View Vimta Labs dividend details including ex-dates and amounts for VIMTALABS stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 0.43% |
| 2024-March | ₹2.00 | 0.40% |
| 2023-March | ₹2.00 | 0.90% |
| 2022-March | ₹2.00 | 1.27% |
| 2021-March | ₹2.00 | 1.27% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹2.00 | 6.70% |
| 2018-March | ₹2.00 | 2.01% |
| 2017-March | ₹0.00 | 0.00% |
Vimta Labs Stock Index Membership
See which indices include Vimta Labs stock.
Check VIMTALABS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vimta Labs Market Events Screener - Corporate Actions
Get Vimta Labs corporate actions including splits, bonuses, and buybacks.
Check Vimta Labs stock events that may affect VIMTALABS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | -3.90% |
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | 8.45% |
| 2025-07-17 | 2025-07-17 | Quarterly Result Announcement | NA | 4.92% |
| 2025-06-13 | 2025-06-13 | Bonus | 1:1 | 6.85% |
| 2025-06-06 | 2025-06-06 | Annual General Meeting | NA | -8.46% |
| 2025-05-30 | 2025-05-30 | Dividend | ₹ 2.00 /share | -9.68% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 10.85% |
| 2025-01-24 | 2025-01-24 | Quarterly Result Announcement | NA | 1.52% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 0.98% |
| 2024-07-18 | 2024-07-18 | Annual General Meeting | NA | 14.19% |
| 2024-07-11 | 2024-07-12 | Dividend | ₹ 2.00 /share | 4.52% |
| 2023-06-21 | 2023-06-22 | Dividend | ₹ 2.00 /share | 6.53% |
| 2022-06-16 | 2022-06-18 | Dividend | ₹ 2.00 /share | -2.05% |
| 2021-06-25 | 2021-06-28 | Dividend | ₹ 2.00 /share | -0.96% |
Vimta Labs Competitors Screener - Peer Comparison
Screen VIMTALABS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 17,596 | 49.77 | 3,714 | 3.77% | 496 | 17.32 |
| Indegene | 11,837 | 25.91 | 2,947 | 10.53% | 407 | 42.93 |
| Suven Life Sciences | 3,456 | -12.55 | 18 | -46.34% | -161 | 46.51 |
| Vimta Labs | 2,177 | 34.07 | 322 | 0.22% | 41 | 44.03 |
| Take Solutions | 698 | 423.09 | 10 | 126.67% | 1 | 64.02 |
| Bilcare | 153 | -3.75 | 807 | 4.78% | -56 | 39.40 |
| Jeevan Scientific Technology | 111 | -53.61 | 48 | 17.87% | 0 | 64.76 |
| Adeshwar Meditex | 30 | 33.09 | 84 | 5.00% | 2 | 25.68 |
| Vanta Bioscience | 14 | -1.06 | 2 | -78.57% | -13 | 14.41 |
Vimta Labs Company Announcements - News Screener
Screen VIMTALABS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-01-28 | Q3 FY- 2025-26 - Unaudited Financial Results | View |
| 2026-01-28 | Board Meeting Outcome for Q3 FY- 2025-26 - Unaudited Financial Results. | View |
| 2026-01-21 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-21 | Board Meeting Intimation for Considering The Financial Results For The Quarter Ended 31St December 2025. | View |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-31 | Closure of Trading Window | View |
| 2025-12-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |